Cite
Protective effects of allergic diseases in COVID‐19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer.
MLA
Santaolalla, Aida, et al. “Protective Effects of Allergic Diseases in COVID‐19 Outcomes: A Retrospective Cohort Study in UK Biobank in the General Population and in Patients with Cancer.” Clinical & Experimental Allergy, vol. 54, no. 4, Apr. 2024, pp. 297–99. EBSCOhost, https://doi.org/10.1111/cea.14445.
APA
Santaolalla, A., Bax, H. J., Chauhan, J., Josephs, D. H., Van, H. M., & Karagiannis, S. N. (2024). Protective effects of allergic diseases in COVID‐19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer. Clinical & Experimental Allergy, 54(4), 297–299. https://doi.org/10.1111/cea.14445
Chicago
Santaolalla, Aida, Heather J. Bax, Jitesh Chauhan, Debra H. Josephs, Hemelrijck, Mieke Van, and Sophia N. Karagiannis. 2024. “Protective Effects of Allergic Diseases in COVID‐19 Outcomes: A Retrospective Cohort Study in UK Biobank in the General Population and in Patients with Cancer.” Clinical & Experimental Allergy 54 (4): 297–99. doi:10.1111/cea.14445.